These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 11270348)

  • 21. Workshop on collaborative studies in prenatal diagnosis of chromosome disease.
    Hamerton J; Boué A; Ferguson-Smith M; Hsu L; Lindsten J; Mikkelsen M; Stene J; Warburton D; Worton R
    Prog Clin Biol Res; 1982; 103 Pt B():369-73. PubMed ID: 7163231
    [No Abstract]   [Full Text] [Related]  

  • 22. [Serum screening of fetal chromosome abnormality during second pregnancy trimester: results of 26,803 pregnant women in Jiangsu Province].
    Hu YL;
    Zhonghua Yi Xue Za Zhi; 2007 Sep; 87(35):2476-80. PubMed ID: 18067809
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Mongolism following omitted amniocentesis].
    Fortschr Med; 1984 Feb; 102(8):68. PubMed ID: 6235162
    [No Abstract]   [Full Text] [Related]  

  • 24. [Prenatal diagnosis of chromosome aberrations after implementation of screening for Down's syndrome].
    Kjaergaard S; Hahnemann JM; Skibsted L; Jensen LN; Sperling L; Zingenberg H; Kristiansen A; Brøndum-Nielsen K
    Ugeskr Laeger; 2008 Mar; 170(14):1152-6. PubMed ID: 18405480
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Changes in the utilization of prenatal diagnosis.
    Benn PA; Egan JF; Fang M; Smith-Bindman R
    Obstet Gynecol; 2004 Jun; 103(6):1255-60. PubMed ID: 15172861
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Attempt at a definition of a coefficient of risk of chromosome abnormalities at the beginning of pregnancy].
    Boué J; Morer I; Vignal P
    J Genet Hum; 1980 Sep; 28(3):149-53. PubMed ID: 7463015
    [No Abstract]   [Full Text] [Related]  

  • 27. Pregnant women's attitudes toward amniocentesis before receiving Down syndrome screening results.
    Brajenović-Milić B; Babić I; Ristić S; Vraneković J; Brumini G; Kapović M
    Womens Health Issues; 2008; 18(2):79-84. PubMed ID: 18180167
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Screening advances and diagnostic choice: the problem of residual risk.
    Henry GP; Britt DW; Evans MI
    Fetal Diagn Ther; 2008; 23(4):308-15. PubMed ID: 18417998
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An evaluation of the decision-making process regarding amniocentesis following a screen-positive maternal serum screen result.
    Kobelka C; Mattman A; Langlois S
    Prenat Diagn; 2009 May; 29(5):514-9. PubMed ID: 19242922
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Normal obstetric ultrasound reduces the risk of Down syndrome in fetuses of older mothers.
    Anderson NG; Luehr B; Ng R
    Australas Radiol; 2006 Oct; 50(5):429-34. PubMed ID: 16981938
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Trisomy 21].
    Robert JM; Cordier MP
    Soins; 1983 Apr; (403):13-6. PubMed ID: 6223376
    [No Abstract]   [Full Text] [Related]  

  • 32. Pregnancy loss rates after midtrimester amniocentesis.
    Eddleman KA; Malone FD; Sullivan L; Dukes K; Berkowitz RL; Kharbutli Y; Porter TF; Luthy DA; Comstock CH; Saade GR; Klugman S; Dugoff L; Craigo SD; Timor-Tritsch IE; Carr SR; Wolfe HM; D'Alton ME
    Obstet Gynecol; 2006 Nov; 108(5):1067-72. PubMed ID: 17077226
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Pregnancy over the age of 40 is no longer a high-risk pregnancy].
    Darbois Y; Lefebvre G; Vauthier D; Camus M
    Rev Prat; 1987 Feb; 37(9):481-7. PubMed ID: 3563356
    [No Abstract]   [Full Text] [Related]  

  • 34. The influence of IVF, multiple gestation and miscarriage on the acceptance of genetic amniocentesis.
    Elimian A; Demsky M; Figueroa R; Ogburn P; Spitzer AR; Gerald Quirk J
    Prenat Diagn; 2003 Jun; 23(6):501-3. PubMed ID: 12813766
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Maternal age-specific fetal loss rates in Down syndrome pregnancies.
    Savva GM; Morris JK; Mutton DE; Alberman E
    Prenat Diagn; 2006 Jun; 26(6):499-504. PubMed ID: 16634111
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rapid prenatal diagnostic testing for Down syndrome only or longer wait for full karyotype: the views of pregnant women.
    Ryan M; Diack J; Watson V; Smith N
    Prenat Diagn; 2005 Dec; 25(13):1206-11. PubMed ID: 16353286
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Antenatal screening for Down syndrome: a smattering of epidemiology].
    Boulvain M; Billieux MH; Irion O
    Rev Med Suisse; 2008 Oct; 4(176):2276-8, 2280. PubMed ID: 19025178
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Decisions about amniocentesis by advanced maternal age patients following maternal serum screening may not always correlate clinically with screening results: need for improvement in informed consent process.
    Marini T; Sullivan J; Naeem R
    Am J Med Genet; 2002 May; 109(3):171-5. PubMed ID: 11977174
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [How to improve the screening and diagnosis of fetal aneuploidy?].
    Ville Y
    Bull Acad Natl Med; 2005 Nov; 189(8):1773-84; discussion 1784-7. PubMed ID: 16737102
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Assessment of demand for prenatal diagnostic testing using willingness to pay.
    Caughey AB; Washington AE; Gildengorin V; Kuppermann M
    Obstet Gynecol; 2004 Mar; 103(3):539-45. PubMed ID: 14990419
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.